Loading...
Therapies for mobility disability in persons with multiple sclerosis
INTRODUCTION: Mobility disability is one of the most widespread and impactful consequences of multiple sclerosis (MS). Disease modifying drugs (DMDs) may delay the progression of disability over time; however, there is minimal evidence supporting the efficacy of DMDs for reversing mobility disabilit...
Saved in:
| Published in: | Expert Rev Neurother |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6291756/ https://ncbi.nlm.nih.gov/pubmed/29772185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737175.2018.1478289 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|